Interactions Between CB1 Receptor and DA Receptors in the Nucleus Accumbens Core

伏核核心 CB1 受体和 DA 受体之间的相互作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): A vast literature has shown that dopamine (DA) signaling in the nucleus accumbens (NAc) is a critical mediator of addiction-related and goal-directed behaviors. Thus, there is considerable interest in understanding the molecular mechanisms through which DA can alter the NAc firing activity and modulate behavior. Previous studies from the Bonci lab found that cooperative activation of DA D1 and D2 receptors increases firing of NAc neurons. Interestingly, many motivated and addiction-related behaviors are sustained by activity of both D1 and D2 receptors in the NAc. Further, cannabinoid type-1 (CB1) receptors in the NAc can also critically regulate motivated behavior. Thus, the main goal of this proposal is to use in vitro techniques, in particular whole-cell patch-clamp electrophysiology in NAc brain slices prepared from adult male rats to understand the molecular mechanisms through which endogenous cannabinoids (eCBs) and CB1 receptor activity could interact with dopamine receptors to enhance NAc firing activity. The long-term goal is to understand how NAcore CB1 and dopamine receptors interact to drive adaptive as well as pathological motivated behaviors, with the hope of developing novel therapeutic interventions for human neurological conditions. My preliminary data indicate that CB1 receptor antagonists prevent the D1/D2 cooperative enhancement of NAc core firing, suggesting that eCB activation of CB1 receptors could play a critical role in this process. However, the cellular mechanisms through which this occurs, especially the type of eCB which might contribute, remain unknown. Specific Aim 1 will examine the contribution of CB1 receptors to the D1/D2-mediated enhancement in NAc core firing. The role of CB1 receptors will be determined with several different CB1 receptor antagonists. The contribution of CB1 receptors will also be examined by investigating whether CB1 receptor activators can enhance NAc core firing alone, or whether interaction with a D1 or D2 receptor agonist is required to enhance firing. Specific Aim 2 will investigate intracellular pathways through which CB1 receptor activation could facilitate NAc core firing. In particular, the identity of the eCB which mediates the CB1/D1/D2 interaction will be examined using inhibitors of PLC, an enzyme critical for several eCB synthesis pathways, and inhibitors of FAAH and MGL, which hydrolyze the eCBs AEA and 2-AG. Also, neurons will be filled with AEA or 2-AG to determine whether these eCBs can increase NAc core firing alone or in combination with D1 or D2 receptor agonists. Together, these experiments will provide important information about the eCB that contributes critically to the D1/D2-mediated enhancement in NAc firing and the possible mechanism(s) through which dopamine and CB1 receptors could interact to enhance NAc firing activity. To facilitate achieving these goals, I will receive ongoing training and mentoring from my sponsor, other lab members, and outside collaborators in the design, implementation, and interpretation of my experiments, in the relevant research literature, and the preparation of my results for submission for publication. PUBLIC HEALTH RELEVANCE: Endogenous cannabinoids (endocannabinoids) modulate many diverse biological targets both in the central nervous system and in the periphery, and therefore play a critical role in many physiological processes such as pain, asthma, glaucoma, nausea, reproduction, immune system and cancer and neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease. Pharmacological manipulation of this system may allow us to identify new therapeutic intervention for several neurological disorders while eliminating the undesirable side effects associated with cannabis. The results from this proposal may be useful in identifying novel signaling interactions that could represent possible pharmacological targets for treating addiction or other diseases.
描述(由申请人提供):大量文献表明,伏核(NAC)中的多巴胺(DA)信号是成瘾相关和目标导向行为的关键中介。因此,人们对了解DA可以改变NAC的激发活性和调节行为的分子机制很感兴趣。Bonci实验室之前的研究发现,DAD1和D2受体的协同激活增加了NAC神经元的放电。有趣的是,许多动机和成瘾相关的行为是由NAC中的D1和D2受体的活动维持的。此外,NAC中的大麻素1型(CB1)受体也可以关键地调节动机行为。因此,本研究的主要目的是利用体外技术,特别是成年雄性大鼠NAC脑片的全细胞膜片钳电生理学,了解内源性大麻素(ECB)和CB1受体活性与多巴胺受体相互作用增强NAC放电活性的分子机制。长期目标是了解NAcore CB1和多巴胺受体是如何相互作用来驱动适应性和病理性动机行为的,希望为人类神经疾病开发新的治疗干预措施。我的初步数据表明,CB1受体拮抗剂阻止了D1/D2协同增强NAC核心放电,表明ECB对CB1受体的激活可能在这一过程中发挥关键作用。然而,这种情况发生的细胞机制,特别是可能起作用的ECB类型,仍然未知。具体目标1将研究CB1受体在D1/D2介导的NAC核心放电增强中的作用。CB1受体的作用将用几种不同的CB1受体拮抗剂来确定。CB1受体的作用也将通过研究CB1受体激动剂是否能单独增强NAC核心放电,或者是否需要与D1或D2受体激动剂相互作用来增强放电来检验。《特定目的2》将研究CB1受体激活促进NAC核心激活的细胞内途径。特别是,将使用PLC的抑制剂以及FAAH和MGL的抑制剂来检查介导CB1/D1/D2相互作用的ECB的同一性。PLC是一种对几种ECB合成途径至关重要的酶,FAAH和MGL是水解ECB AEA和2-AG的抑制剂。此外,还将用AEA或2-AG填充神经元,以确定这些ECB是否可以单独或与D1或D2受体激动剂联合使用来增加NAC核心放电。综上所述,这些实验将提供有关欧洲央行在D1/D2介导的NAC放电增强中起关键作用的重要信息,以及多巴胺和CB1受体相互作用增强NAC放电活性的可能机制(S)。为了促进这些目标的实现,我将接受赞助商、其他实验室成员和外部合作者的持续培训和指导,帮助我在相关研究文献中设计、实施和解释我的实验,并准备我的结果以供发表。 与公共健康相关:内源性大麻素(内源性大麻素)在中枢神经系统和外周调节许多不同的生物靶点,因此在许多生理过程中发挥关键作用,如疼痛、哮喘、青光眼、恶心、生殖、免疫系统和癌症以及神经退行性疾病,如帕金森氏病和阿尔茨海默病。对这一系统的药理学操作可能使我们能够确定几种神经疾病的新治疗干预措施,同时消除与大麻相关的不良副作用。这一提议的结果可能有助于识别新的信号相互作用,这些信号相互作用可能代表治疗成瘾或其他疾病的可能的药理靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Taban none Seif其他文献

Taban none Seif的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Taban none Seif', 18)}}的其他基金

Interactions Between CB1 Receptor and DA Receptors in the Nucleus Accumbens Core
伏核核心 CB1 受体和 DA 受体之间的相互作用
  • 批准号:
    8309317
  • 财政年份:
    2010
  • 资助金额:
    $ 5.05万
  • 项目类别:
Interactions Between CB1 Receptor and DA Receptors in the Nucleus Accumbens Core
伏核核心 CB1 受体和 DA 受体之间的相互作用
  • 批准号:
    8139035
  • 财政年份:
    2010
  • 资助金额:
    $ 5.05万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 5.05万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 5.05万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 5.05万
  • 项目类别:
Downsides of downhill: The adverse effects of head vibration associated with downhill mountain biking on visuomotor and cognitive function
速降的缺点:与速降山地自行车相关的头部振动对视觉运动和认知功能的不利影响
  • 批准号:
    2706416
  • 财政年份:
    2022
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了